Trial Profile
A randomised controlled trial on efficacy and safety of intrvenous ferric carboxymaltose verus intravenous iron sucrose complex in the treatment of iron deficiency anemia in women with benign gynaecological disorders.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary) ; Iron sucrose
- Indications Iron deficiency anaemia
- Focus Adverse reactions; Therapeutic Use
- 18 Mar 2014 New trial record